|
|
In September 2009 global leaders committed to reform over-the-counter (OTC) derivatives markets with the key objectives of reducing systemic risk, improving transparency, supporting financial stability and combatting market abuse. These high level commitments have now been translated into concrete rules and actions, with global jurisdictions at differing stages of implementation.
However the implementation of these rules at a global level has thrown up challenges as the constraints of domestic law, differences in market structure and timing hamper the ability for rules to work globally across the spectrum of market participants. The need for a consistent and coordinated approach from regulators is essential. Without it there is a real risk that market participants will be subject to conflicting, duplicative or over-lapping requirements.
In this paper, commissioned by the Securities Industry and Financial Markets Association (SIFMA) and the Association for Financial Markets in Europe (AFME), Deloitte considers the approaches taken in the two largest derivatives markets: the EU and the US. It compares the detailed EU requirements against the 15 categories identified by the Commodity Futures Trading Commission (CFTC) in its proposed interpretative guidance for the cross-border application of rules. In summary it finds:
Overall, from an outcomes-based perspective, the EU package of derivatives regulation is likely to lead to a broadly similar set of outcomes, as envisaged by the 15 categories identified by the CFTC in its proposed interpretative guidance on the cross-border application of OTC derivatives requirements.